Biolab Research, LLC

Rockville, Maryland 20852-1542

0 studies enrolling now · 8 studies all time

What they study most

Alport Syndrome, Chronic Kidney Disease (CKD) Stage 5, Diabetes Mellitus, Type 2, Diabetic Kidney Disease, Diabetic Nephropathies, Hyperphosphatemia, Hypertrophy, Left Ventricular, Renal Insufficiency, Renal Insufficiency, Chronic

Studies at this site

• A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL — Completed
• Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria — Completed
• Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol) — Completed
• Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (28-week Extension Study) — Completed
• Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency — Completed
• A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy — Completed
• The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5 — Stopped early
• Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly) — Completed